Eli Lilly to invest $1.8bn in manufacturing capacity in Ireland
Eli Lilly and Company has announced a significant expansion of its manufacturing presence in Ireland, with a $1bn investment earmarked for its Limerick site. The move is aimed at boosting the company’s production of biologic active ingredients, including those for its approved Alzheimer's treatment.
Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above ...
Shares of Eli Lilly & Co. LLY shed 1.21% to $923.71 Friday, on what proved to be an all-around positive trading session for ...
Sold under the brand names Mounjaro and Zepbound, tirzepatide has been an incredible growth driver for Eli Lilly. In 2022 -- ...
The Switzerland-based pharmaceutical company has been trying to crack the weight-loss boom currently dominated by Eli Lilly ...
Eli Lilly (LLY) stock gained as Citi resumed its covderage with a buy rating and $1,060 price target, citing optimism for its ...
Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound) ...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 607.25% and ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Eli Lilly and Novo Nordisk have been top stocks for investors who are bullish on the weight loss market. However, fellow ...
Four years after launching a remote-controlled robotic laboratory in San Diego, Eli Lilly is shipping the operation overseas.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback